| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |